Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study

被引：0
|
作者：
Naoto Iwai
Hiroaki Sakai
Kohei Oka
Junichi Sakagami
Takashi Okuda
Chie Hattori
Masashi Taniguchi
Tasuku Hara
Toshifumi Tsuji
Toshiyuki Komaki
Keizo Kagawa
Toshifumi Doi
Takeshi Ishikawa
Hiroaki Yasuda
Yoshito Itoh
机构：
[1] Fukuchiyama City Hospital,Department of Gastroenterology and Hepatology
[2] Kyoto Prefectural University of Medicine,Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Anamorelin; Lean body mass; Gastrointestinal cancer; Response; Clinical settings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Pharmacological management update: clinical significance of anamorelin clinical trials for the treatment of cancer cachexia in advanced cancer patients
    De Ng, Terence Rong
    Bruera, Eduardo
    Yennurajalingam, Sriram
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S491 - S496
  • [42] A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients
    McMillan, DC
    OGorman, P
    Fearon, KCH
    McArdle, CS
    BRITISH JOURNAL OF CANCER, 1997, 76 (06) : 788 - 790
  • [43] An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia
    Fonseca, Guilherme Wesley Peixoto Da
    von Haehling, Stephan
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (07) : 889 - 895
  • [44] A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients
    DC McMillan
    P O'Gorman
    KCH Fearon
    CS McArdle
    British Journal of Cancer, 1997, 76 : 788 - 790
  • [45] Anamorelin in the Management of Cancer Cachexia: Clinical Efficacy, Challenges, and Future Directions
    Fujii, Hironori
    Yamada, Yunami
    Iihara, Hirotoshi
    Kobayashi, Ryo
    Suzuki, Akio
    ANTICANCER RESEARCH, 2025, 45 (03) : 865 - 881
  • [46] Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
    Takeda, Tsuyoshi
    Sasaki, Takashi
    Okamoto, Takeshi
    Ishitsuka, Takahiro
    Yamada, Manabu
    Nakagawa, Hiroki
    Mie, Takafumi
    Furukawa, Takaaki
    Kasuga, Akiyoshi
    Matsuyama, Masato
    Ozaka, Masato
    Sasahira, Naoki
    INTERNAL MEDICINE, 2023, 62 (13) : 1887 - 1893
  • [47] A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3.
    Currow, David Christopher
    Temel, Jennifer S.
    Fearon, Kenneth
    Yan, Ying
    Friend, John
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] A preponderance of gastrointestinal cancer patients transition into cachexia syndrome
    Gilmore, Linda Anne
    Olaechea, Santiago
    Gilmore, Brian W.
    Gannavarapu, Bhavani S.
    Alvarez, Christian M.
    Ahn, Chul
    Iyengar, Puneeth
    Infante, Rodney E.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (06) : 2920 - 2931
  • [49] ROMANA 3: A safety extension study of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with cachexia
    Currow, D.
    Temel, J.
    Fearon, K.
    Friend, J.
    Yan, Y.
    Abernethy, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S239 - S239
  • [50] Predictors of therapeutic efficacy of anamorelin in patients with gastric, pancreatic, and colorectal cancer.
    Shimomura, Kazuhiro
    Ogata, Takatsugu
    Maeda, Akimitsu
    Narita, Yukiya
    Taniguchi, Hiroya
    Murotani, Kenta
    Tajika, Masahiro
    Hara, Kazuo
    Muro, Kei
    Uchida, Kosaku
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 331 - 331
12345